178 251

Cited 20 times in

Baseline Characteristics of the Korean Registry of Pulmonary Arterial Hypertension

 Wook Jin Chung  ;  Yong Bum Park  ;  Chan Hong Jeon  ;  Jo Won Jung  ;  Kwang Phil Ko  ;  Sung Jae Choi  ;  Hye Sun Seo  ;  Jae Seung Lee  ;  Hae Ok Jung 
 JOURNAL OF KOREAN MEDICAL SCIENCE, Vol.30(10) : 1429-1438, 2015 
Journal Title
Issue Date
Adult ; Aged ; Connective Tissue Diseases/complications ; Data Collection ; Databases, Factual* ; Familial Primary Pulmonary Hypertension/epidemiology* ; Familial Primary Pulmonary Hypertension/mortality ; Familial Primary Pulmonary Hypertension/therapy ; Female ; Heart Defects, Congenital/complications ; Humans ; Internet ; Male ; Middle Aged ; Prognosis ; Prospective Studies ; Pulmonary Artery/physiopathology* ; Registries* ; Republic of Korea/epidemiology ; Survival Rate ; Young Adult
Hypertension, Pulmonary ; Korean ; Prognosis ; Pulmonary Arterial Hypertension
Despite recent advances in understanding of the pathobiology and targeted treatments of pulmonary arterial hypertension (PAH), epidemiologic data from large populations have been limited to western countries. The aim of the Korean Registry of Pulmonary Arterial Hypertension (KORPAH) was to examine the epidemiology and prognosis of Korean patients with PAH. KORPAH was designed as a nationwide, multicenter, prospective data collection using an internet webserver from September 2008 to December 2011. A total of 625 patients were enrolled. The patients' mean age was 47.6 ± 15.7 yr, and 503 (80.5%) were women. The diagnostic methods included right heart catheterization (n = 249, 39.8%) and Doppler echocardiography (n = 376, 60.2%). The etiologies, in order of frequency, were connective tissue disease (CTD), congenital heart disease, and idiopathic PAH (IPAH) (49.8%, 25.4%, and 23.2%, respectively). Patients with WHO functional class III or IV at diagnosis were 43.4%. In total, 380 (60.8%) patients received a single PAH-specific treatment at the time of enrollment, but only 72 (18.9%) patients received combination therapy. Incident cases during the registry represented 297 patients; therefore, the incidence rate of PAH was 1.9 patients/yr/million people. The 1st-, 2nd-, and 3rd-yr estimated survival rates were 90.8%, 87.8%, and 84.4%, respectively. Although Korean PAH patients exhibited similar age, gender, and survival rate compared with western registries, they showed relatively more CTD-PAH in the etiology and also systemic lupus erythematosus among CTD-PAH. The data suggest that earlier diagnosis and more specialized therapies should be needed to improve the survival of PAH patients.
Files in This Item:
T201504143.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아청소년과학교실) > 1. Journal Papers
Yonsei Authors
Jung, Jo Won(정조원)
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.